Healthcare - Biotechnology - NASDAQ - CA
$ 1.7
-6.08 %
$ 90.6 M
Market Cap
-1.68
P/E
INCOME STATEMENT
1 M
REVENUE
-61.1 M
OPERATING INCOME
-59.7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Milestone Pharmaceuticals Inc.
| Revenue | 1 M |
| Cost Of Revenue | 598 K |
| Gross Profit | 402 K |
| Operating Expenses | 62.1 M |
| Operating Income | -61.1 M |
| Other Expenses | -1.41 M |
| Net Income | -59.7 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 1.0 | 5.0 | 15.0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0.6 | 0.5 | 0 | 0.4 | 0.2 | 10 K | 8 K |
| Gross Profit | 0.4 | 4.5 | 15.0 | (0.4) | (0.2) | 10 K | 8 K |
| OPERATING INCOME | |||||||
| Operating Expenses | 62.1 | 64.6 | 58.1 | 50.7 | 57.9 | 23.8 | 8.3 |
| Selling, General and Administrative Expenses | 31.0 | 24.8 | 19.4 | 16.2 | 15.9 | 7.0 | 2.6 |
| Research and Development Expenses | 31.1 | 39.8 | 38.7 | 34.5 | 42.0 | 16.8 | 5.6 |
| Operating Income | (61.1) | (59.6) | (43.1) | (50.7) | (57.9) | (23.8) | (8.3) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 2.6 | 0 | 0 | 0.7 | 2.6 | 0 | 0 |
| Total Other Income | 1.4 | 1.3 | 0.2 | 0.7 | 2.6 | 0.7 | 0.2 |
| Pre-Tax Income | (59.7) | (58.4) | (42.9) | (50.0) | (55.3) | (23.1) | (8.1) |
| NET INCOME | |||||||
| Tax Provision | 0 | (1.3) | (0.2) | 17 K | 56 K | 74 K | 4 K |
| Net Income | (59.7) | (57.1) | (42.6) | (50.0) | (55.2) | (23.2) | (8.1) |
| EPS | 1.39 | 1.35 | 1.02 | 1.7 | 3.5 | 0.98 | 0.34 |